Phio Pharmaceuticals Corp. (PHIO) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Phio Pharmaceuticals Corp. (PHIO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $12.8M, listed on NASDAQ, employing roughly 5 people, carrying a beta of 0.84 to the broader market. Phio Pharmaceuticals Corp. Led by Robert J. Bitterman, public since 2012-05-10.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for PHIO as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →